Principal Investment Grade Corporate Active ETF (IG)
- Previous Close
20.11 - Open
20.10 - Bid --
- Ask 24.94 x 1000
- Day's Range
20.01 - 20.10 - 52 Week Range
19.05 - 21.10 - Volume
14,627 - Avg. Volume
20,025 - Net Assets 77.47M
- NAV 20.05
- PE Ratio (TTM) --
- Yield 4.62%
- YTD Daily Total Return -3.21%
- Beta (5Y Monthly) 1.26
- Expense Ratio (net) 0.19%
The fund is an actively managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets, plus any borrowings for investment purposes, in investment grade corporate bonds and other fixed income securities at the time of purchase. "Investment grade" securities are rated BBB- or higher by S&P Global Ratings ("S&P Global") or Baa3 or higher by Moody's Investors Service, Inc. ("Moody's") or, if unrated, of comparable quality in the opinion of those selecting such investments.
Principal Funds
Fund Family
Corporate Bond
Fund Category
77.47M
Net Assets
2018-04-18
Inception Date
Performance Overview: IG
Trailing returns as of 4/24/2024. Category is Corporate Bond.
People Also Watch
Related ETF News
Research Reports: IG
CORT: Lowering target price to $18.00
CORCEPT THERAPEUTICS INC has an Investment Rating of SELL; a target price of $18.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.
RatingPrice TargetCORT: Lowering target price to $19.00
CORCEPT THERAPEUTICS INC has an Investment Rating of SELL; a target price of $19.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.
RatingPrice TargetCORT: What does Argus have to say about CORT?
CORCEPT THERAPEUTICS INC has an Investment Rating of SELL; a target price of $20.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.
RatingPrice TargetCORT: Lowering target price to $20.00
CORCEPT THERAPEUTICS INC has an Investment Rating of SELL; a target price of $20.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.
RatingPrice Target